Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion type Assertion NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_head.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion wasGeneratedBy ECO_0000203 NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_provenance.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion wasDerivedFrom befree-20140225 NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_provenance.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion SIO_000772 17959715 NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_provenance.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion evidence source_evidence_literature NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_provenance.
- NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_assertion description "[Carrier frequency of the MLH1 -93 variant was higher in patients who developed therapy related acute myeloid leukaemia (t-AML) (75.0%, n = 12) or breast cancer (53.3%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP213596.RAzEnHx-M2EUZWGdZqxUzvQdlzPwds_owGhZWJICbSUDs130_provenance.